The Australian Synchrotron became available for routine microbeam radiation therapy (MRT) experiments during 2011. The availability of this world class facility in Australia opens the door to studies that have the potential to substantially improve radiotherapy for cancer, as well as advancing understanding of fundamental radiobiology.
This project will investigate why MRT appears to give superior results to conventional radiotherapy, and start to establish criteria for clinical use of MRT to treat cancers.
Prof Peter Rogers, Dr Jeffrey Crosbie, Dr Yuqing Yang, Dr Premila Paiva
Cancer Council Victoria Research Grant
The University of Melbourne